The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Prostatectomy, and Nephrectomy.

Stuart Leitner is a Hematologist Oncology specialist and a Hematologist in Livingston, New Jersey. Dr. Leitner is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Leitner is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Karleung Siu is a Hematologist and an Oncologist in Florham Park, New Jersey. Dr. Siu is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Mark Mann is a Urologist in Berkeley Heights, New Jersey. Dr. Mann is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostatectomy, and Ureteroscopy. Dr. Mann is currently accepting new patients.

Joshua Fiske is a Urologist in Westfield, New Jersey. Dr. Fiske is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Boils, and Ureteroscopy. Dr. Fiske is currently accepting new patients.

Jeffrey Katz is a Urologist in Livingston, New Jersey. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are UPJ Obstruction, Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Ureteroscopy. Dr. Katz is currently accepting new patients.

Rhonda Walsh is a Urologist and an Obstetrics and Gynecologist in Livingston, New Jersey. Dr. Walsh is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Eosinophilic Cystitis, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, and Ureteroscopy. Dr. Walsh is currently accepting new patients.

Adeep Thumar is a Urologist in Livingston, New Jersey. Dr. Thumar is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Retroperitoneal Fibrosis, Intussusception in Children, Obstructive Uropathy, Prostatectomy, and Ureteroscopy. Dr. Thumar is currently accepting new patients.

James Orsini is a Hematologist in West Orange, New Jersey. Dr. Orsini is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Lung Cancer, Colorectal Cancer, Iron Deficiency Anemia, Familial Prostate Cancer, and Bone Marrow Aspiration.

Said Saleh is a Hematologist in West Orange, New Jersey. Dr. Saleh is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy.

Indu Sabnani is a Hematologist and an Oncologist in Maplewood, New Jersey. Dr. Sabnani is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Familial Colorectal Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Sabnani is currently accepting new patients.

John Gianis is a Urologist in Summit, New Jersey. Dr. Gianis is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urothelial Cancer, Enlarged Prostate (BPH), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Gianis is currently accepting new patients.

Dr. Naeem Rahman is the medical director for Atlantic Medical Group Urology in Union and Somerset Counties. A board-certified urologist, he specializes in the treatment of urological cancers, with a focus on prostate and bladder cancer, as well as diseases and disorders of the urinary tract in both men and women. With nearly 20 years of professional experience, Dr. Rahman is known for his expertise in nerve-sparing surgery, robotic surgery, open surgery, and advanced focal therapies like cryotherapy and ablation for salvage prostate cancer. He is committed to restoring normal function and improving the quality of life for his patients, offering a comprehensive, multidisciplinary approach to prostate cancer treatment, including active surveillance and a focus on men’s sexual health.Dr. Rahman delivers concierge-level care, providing both surgical and clinical excellence while maintaining a warm, compassionate approach. He served as chief of Urology and director of Robotic Surgery at Vassar Brothers Medical Center in Poughkeepsie, NY, overseeing nearly 1,000 robotic and laparoscopic procedures. In addition, he directed an advanced prostate cancer clinic, providing the latest treatment options for patients with disease progression. His practice offers a robust male sexual health medicine program, with specialized care for erectile dysfunction (ED).Dedicated to advancing state-of-the-art therapeutics, Dr. Rahman has served as a primary investigator on several clinical trials for bladder and prostate cancer. He is a member of the American Urological Association and the Society of Robotic Surgery. After earning his degree from Wake Forest University School of Medicine, Winston-Salem, NC, Dr. Rahman completed residency programs in surgery and urology at Eastern Virginia Medical School in Norfolk, VA. He is an assistant clinical professor at New York Medical College, Valhalla, NY. Dr. Rahman is also a participating provider of the Atlantic Accountable Care Organization. Dr. Rahman is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bilateral Hydronephrosis, Ureteroscopy, and Prostatectomy.

I like to inform and educate my patients to include them in the decision process and intervene only when necessary. I will be facile and choose what’s best for the patient according to the circumstances while listening for the answer — it’s usually in the complaint — and being compassionate. Dr. Kaynan is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Hydronephrosis, Reconstructive Urology Surgery, and Ureteroscopy.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.

Dr. Pressler always strives to provide compassionate and personalized care for all of his patients. He is a recognized regional expert in urologic oncology and robotic surgery. Dr. Pressler has the most experience using the da Vinci robot in northwest NJ. Dr. Pressler specializes in robotic prostatectomy, cystectomy, partial, nephrectomy and urinary tract reconstruction. He is the only urologist in NJ to perform neobladder reconstruction entirely robotic/laparoscopically. Dr. Pressler is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Hydronephrosis, Obstructive Uropathy, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction.